JP2022500418A5 - - Google Patents
Info
- Publication number
- JP2022500418A5 JP2022500418A5 JP2021513958A JP2021513958A JP2022500418A5 JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5 JP 2021513958 A JP2021513958 A JP 2021513958A JP 2021513958 A JP2021513958 A JP 2021513958A JP 2022500418 A5 JP2022500418 A5 JP 2022500418A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- phenyl
- deuteroalkyl
- alkoxy
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862730602P | 2018-09-13 | 2018-09-13 | |
| US62/730,602 | 2018-09-13 | ||
| PCT/US2019/050719 WO2020056072A1 (en) | 2018-09-13 | 2019-09-12 | 1h-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (ripk1) |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022500418A JP2022500418A (ja) | 2022-01-04 |
| JP2022500418A5 true JP2022500418A5 (https=) | 2022-09-05 |
| JPWO2020056072A5 JPWO2020056072A5 (https=) | 2022-09-05 |
| JP7599411B2 JP7599411B2 (ja) | 2024-12-13 |
Family
ID=68073171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513958A Active JP7599411B2 (ja) | 2018-09-13 | 2019-09-12 | 受容体相互作用タンパク質キナーゼ１阻害剤（ｒｉｐｋ１）としての１ｈ－インダゾールカルボキサミド |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12172975B2 (https=) |
| EP (1) | EP3849968B1 (https=) |
| JP (1) | JP7599411B2 (https=) |
| KR (1) | KR102906523B1 (https=) |
| CN (1) | CN112673000B (https=) |
| AU (1) | AU2019337612A1 (https=) |
| BR (1) | BR112021004385A2 (https=) |
| CA (1) | CA3112735A1 (https=) |
| EA (1) | EA202190718A1 (https=) |
| ES (1) | ES2936481T3 (https=) |
| IL (1) | IL281370A (https=) |
| MX (1) | MX2021002509A (https=) |
| SG (1) | SG11202102405YA (https=) |
| WO (1) | WO2020056072A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE058292T2 (hu) | 2017-10-30 | 2022-07-28 | Bristol Myers Squibb Co | Aminoimidazopiridazinok mint kináz inhibitorok |
| CN112262139B (zh) | 2018-01-26 | 2023-07-25 | 百时美施贵宝公司 | 作为激酶抑制剂的氨基吡咯并三嗪 |
| AU2019339355A1 (en) | 2018-09-13 | 2021-05-13 | Bristol-Myers Squibb Company | Indazole carboxamides as kinase inhibitors |
| ES2969756T3 (es) * | 2019-10-03 | 2024-05-22 | Bristol Myers Squibb Co | Indazol carboxamidas como inhibidores de cinasas |
| EP4214207A4 (en) | 2020-09-15 | 2024-10-02 | 1st Biotherapeutics, Inc. | 2-AMINO-3-CARBONYL IMIDAZOPYRIDINE AND PYRAZOLOPYRIDINE COMPOUNDS |
| AR123793A1 (es) | 2020-10-19 | 2023-01-11 | Bristol Myers Squibb Co | Compuestos de triazolopiridinilo como inhibidores de quinasas |
| WO2025106362A1 (en) * | 2023-11-16 | 2025-05-22 | Merck Sharp & Dohme Llc | Ripk1 inhibitors and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4836788B2 (ja) | 2003-07-23 | 2011-12-14 | エグゼリクシス， インコーポレイテッド | 未分化リンパ腫キナーゼ変調因子及びその使用法 |
| RU2418797C2 (ru) | 2004-12-22 | 2011-05-20 | Мемори Фармасьютиклз Корпорейшн | Лиганды никотинового рецептора альфа-7, их получение и применение |
| UA92083C2 (ru) | 2006-05-19 | 2010-09-27 | Эбботт Леборетриз | Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом |
| KR101061599B1 (ko) | 2008-12-05 | 2011-09-02 | 한국과학기술연구원 | 비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물 |
| WO2010068287A2 (en) | 2008-12-11 | 2010-06-17 | Angion Biomedica Corp. | Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| EA020017B1 (ru) | 2009-04-30 | 2014-08-29 | Новартис Аг | Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ |
| US8455516B2 (en) | 2010-01-15 | 2013-06-04 | Touro University | HIV-1 fusion inhibitors and methods |
| KR20130077390A (ko) * | 2011-12-29 | 2013-07-09 | 제이더블유중외제약 주식회사 | 단백질 키나아제 저해활성을 가지는 6-아미노-3-카복스아미도인다졸 유도체 |
| RS54539B1 (sr) | 2012-02-21 | 2016-06-30 | Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. | Upotreba 1h-indazol-3-karboksamidnih jedinjenja kao inhibitora kinaze 3-beta glikogen sintetaze |
| CA2860250C (en) | 2012-02-21 | 2020-11-10 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| WO2014047024A1 (en) | 2012-09-18 | 2014-03-27 | Bristol-Myers Squibb Company | Iap antagonists |
| CN104781251B (zh) * | 2012-11-08 | 2016-12-14 | 百时美施贵宝公司 | 可作为激酶调节剂的经双环杂环取代的吡啶基化合物 |
| MX2016012208A (es) | 2014-03-20 | 2017-01-26 | Samumed Llc | Indazol-3-carboxamidas 5-substituidas y preparacion y uso de las mismas. |
| EP3463355B1 (en) | 2016-05-26 | 2024-08-28 | Sonic Master Limited | Modulators of dux4 for regulation of muscle function |
| MA47460A (fr) | 2017-02-13 | 2019-12-18 | Bristol Myers Squibb Co | Aminotriazolopyridines utilisées en tant qu'inhibiteurs de kinase |
| HUE058292T2 (hu) | 2017-10-30 | 2022-07-28 | Bristol Myers Squibb Co | Aminoimidazopiridazinok mint kináz inhibitorok |
| CN112262139B (zh) | 2018-01-26 | 2023-07-25 | 百时美施贵宝公司 | 作为激酶抑制剂的氨基吡咯并三嗪 |
| AU2019339355A1 (en) | 2018-09-13 | 2021-05-13 | Bristol-Myers Squibb Company | Indazole carboxamides as kinase inhibitors |
| ES2969756T3 (es) | 2019-10-03 | 2024-05-22 | Bristol Myers Squibb Co | Indazol carboxamidas como inhibidores de cinasas |
-
2019
- 2019-09-12 KR KR1020217010498A patent/KR102906523B1/ko active Active
- 2019-09-12 BR BR112021004385-3A patent/BR112021004385A2/pt not_active Application Discontinuation
- 2019-09-12 US US17/274,220 patent/US12172975B2/en active Active
- 2019-09-12 SG SG11202102405YA patent/SG11202102405YA/en unknown
- 2019-09-12 MX MX2021002509A patent/MX2021002509A/es unknown
- 2019-09-12 EA EA202190718A patent/EA202190718A1/ru unknown
- 2019-09-12 ES ES19779240T patent/ES2936481T3/es active Active
- 2019-09-12 WO PCT/US2019/050719 patent/WO2020056072A1/en not_active Ceased
- 2019-09-12 JP JP2021513958A patent/JP7599411B2/ja active Active
- 2019-09-12 AU AU2019337612A patent/AU2019337612A1/en not_active Abandoned
- 2019-09-12 EP EP19779240.1A patent/EP3849968B1/en active Active
- 2019-09-12 CA CA3112735A patent/CA3112735A1/en active Pending
- 2019-09-12 CN CN201980059445.8A patent/CN112673000B/zh active Active
-
2021
- 2021-03-09 IL IL281370A patent/IL281370A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022500418A5 (https=) | ||
| AU2017283769B2 (en) | Compounds and compositions for inhibiting the activity of SHP2 | |
| JP2017511815A5 (https=) | ||
| JP6196156B2 (ja) | 過剰増殖性障害および血管新生に関連する疾患の治療のために有用なアミノアルコール置換２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリン誘導体 | |
| ES2660831T3 (es) | Derivados de imidazol condensados útiles como inhibidores de IDO | |
| JP2019512505A5 (https=) | ||
| JP2022501334A5 (https=) | ||
| KR20220027822A (ko) | 헤테로시클릭 화합물 및 연충 감염 및 질환의 치료를 위한 그의 용도 | |
| JP2014531449A5 (https=) | ||
| ES2639402T3 (es) | 2,3-dihidroimidazo[1,2-c]quinolinas sustituidas con arilaminoalcohol | |
| EP3713922A1 (en) | Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides | |
| RU2012117398A (ru) | Бензоксазепиновые ингибиторы pi3 и способы применения | |
| AU2017269870A1 (en) | 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides | |
| RU2012156940A (ru) | Лекарственные средства, индуцирующие апоптоз, для лечения рака и иммунных и аутоиммунных заболеваний | |
| RU2010110036A (ru) | Производные пиперидина в качестве агонистов мускариновых рецепторов | |
| CN103561576A (zh) | 脂质合成的杂环调节剂 | |
| JPWO2023018810A5 (https=) | ||
| JP2021514373A5 (https=) | ||
| RU2014115476A (ru) | Производные пиразоло[4, 3-с]птридина в качестве ингибиторов киназ | |
| CN107108554B (zh) | 作为midh1抑制剂用于治疗肿瘤的1-环己基-2-苯基氨基苯并咪唑 | |
| EA037517B1 (ru) | Антипролиферативные соединения и их фармацевтические композиции и применения | |
| RU2010136721A (ru) | Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления | |
| JP2017533205A (ja) | ｍＩＤＨ１阻害剤としてのベンゾイミダゾール−２−アミン | |
| JP2020520957A5 (https=) | ||
| JP6165058B2 (ja) | アルコキシ−置換２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリン |